Biofrontera Inc. (BFRI)
Biofrontera Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Woburn, MA, US. The stock last traded at $0.53, down 7.02% on the session, giving a market capitalisation of $7.9M. On trailing twelve-month figures it carries a trailing P/E of -1.33, a net margin of -12.7%. Its beta of 0.96 implies it has historically moved less than the broad market.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc. is most often compared with the following Healthcare names: